Clinical implications of selective cyclooxygenase-2 inhibition

Scandinavian Journal of Rheumatology, Supplement

Volumn 25, Issue 102, 1996, Pages 23-28

  Emery, P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Clinical; Cyclooxygenase; NSAIDs; Osteoarthritis; Rheumatoid arthritis; Safety; Synoviocytes

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL ESTER; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; ANTIRHEUMATIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ANALGESIA; ARTHRITIS; CONFERENCE PAPER; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; INFLAMMATION; NONARTICULAR RHEUMATISM; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; SYNOVIUM; ARTICLE; ENZYMOLOGY; PHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; OSTEOARTHRITIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SYNOVIAL MEMBRANE;

EID: 0029935247     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609097227     Document Type: Conference Paper

References (23)

1. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterol 1989; 96:647-55.
2. Kleinknecht D. Diseases of the kidney caused by non steroidal anti-inflammatory drugs. In: Stewart JH, Ed. Analgesic and NSAID-induced kidney disease. Oxford: Oxford University Press, 1993: 160-79.
3. Vane J. Towards a better aspirin. Nature 1994; 367:215-6.
4. Sano H, Hla T, Maier JAM, Crofford LJ, Case JP, Maciag T et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptocoocal cell wall arthritis. J Clin Invest 1992; 89:97-108.
5. Crofford LJ, Wilder RL, Ristimaki AP et al. Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester and corticosteroids. J Clin Invest 1994; 93:1095-101.
6. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33(3):305-15.
7. Fries JF, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease modifying antirheumatic drugs. Arthritis Rheum 1993; 36:297-306.
8. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol 1990; 17(22): 12-5.
9. Young A, Cox N, Dixie J, James D, Gough A, Gallivan S et al. Early Rheumatoid Arthritis Study (ERAS). Report of first 506 patients. Arthritis Rheum 1991; 34(9):48.
10. Fuchs H, Kaye JJ, Callahan LF, Nance PE, Pincus T. Evidence of significant radiographic damage in RA within the first two years of disease. J Rheumatol 1989; 16:585-91.
11. Emery P (Ed). Management of early inflammatory arthritis. In: Clinical Rheumatology. Balliere Tindall, 1992.
12. McAlindon T, Dieppe P. The medical management of osteoarthritis of the knee: an inflammatory issue? Brit J Rheumatol 1990; 29:471-3.
13. Brandt KD. Should osteoarthritis be treated with non-steroidal anti-inflammatory drugs? Rheumatic Disease Clinics of North America 1993; 19(3):697-712.
14. Ledingham J, Regan M, Jones A, Doherty M. Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis 1995; 54(1):53-8.
15. Lindblad S, Hedfors F. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987; 30(10):1081-8.
16. Loose LD, De Oliveira R, Sipe JD, Franzhlau C, Shanahan WR. A possible systemic component of osteoarthritis (OA): Elevated concentrations (by ELISA) of C-reactive protein (CRP) in serum of OA patients and modulation by lenidap. Arthritis Rheum 1993; 36(Suppl 9):S166.
17. Kennedy TD, Plater Zyberk C, Partridge TA. Woodrow DF, Maini RN. Morphometric comparison of synovium from patients with osteoarthritis and rheumatoid arthritis. J Clin Pathol 1988; 41(8):847-52.
18. Williams HJ, Ward JR, Egger MJ, Neuner R. Brooks RH. Clegg DO, el al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993; 36(9): 1196-206.
19. Bradley JD. Brandt KD, Katz BP, Kalasinski LA. Ryan SI. Comparison of an anti-inflammatory dose of ibuprofen. an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Eng J Med 1991; 325(2): 125-7.
20. Dieppe P, Cushnaghan J, Jasani MK, McCrae F, Watt I. A two-year placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol 1993; 32(7):529-31.
21. Dekker J, Boot B, van der Woude LHV, Bijlsma JWJ. Pain and disability in osteoarthritis: a review of biobehavioural mechanisms. J Behav Med 1992; 15:189-214.
22. Dekker J, Tola P, Aufdemkampe G, Winckers M. Negative affect, pain and disability in osteoarthritis patients: the mediating role of muscle weakness. Behav Res Ther 1993; 31(2):203-6.
23. 2 and cyclooxygenase-2. Eur J Biochem 1994; 226:125-31.